Weight Loss News and Research

Latest Weight Loss News and Research

Scientists discover four new genetic variants in humans linked with NAFLD

Five genetic variants in humans - four new - associate with Nonalcoholic Fatty Liver Disease, according to a study published March 10 in PLoS Genetics.

10 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

Patients with epilepsy-linked memory loss worry more than their physicians

Patients with epilepsy worry more than their physicians do about the patients' potential memory loss accompanying their seizure disorder, according to a recent study.

9 Mar 2011

First POSE procedure using USGI's Incisionless Operating Platform performed at Ospedale All'Angelo

USGI Medical, Inc. announced that a prominent surgeon in Italy performed the first POSE procedure on patients for weight loss.

8 Mar 2011

1 800 GET THIN to sponsor Wendy's Knowledge Is Power program

1 800 GET THINSM is proud to sponsor Wendy Carrillo in this year's Walk for Wishes and encourages you to live a healthier life, get involved in your community and help brighten children's lives, one step at a time! Wendy Carrillo is the host of Knowledge Is Power, Power 106 FM's Los Angeles community platform where awareness on issues that matter to Angelenos are raised.

5 Mar 2011

Study: Overweight adolescents may have high risk of less bone mass

Overweight adolescents already struggling with risk factors such as insulin resistance may need to add weak bones to their list of health concerns, researchers report.

5 Mar 2011

Bariatric surgery can reduce significant weight in severely obese adolescents

"Bariatric surgery" refers to several different surgical procedures designed to assist weight loss by limiting the amount of food someone eats or the amount they absorb during digestion. It has been used for several years to treat obesity in adults.

4 Mar 2011

Weight-loss surgery successful in treating overweight adolescents

“Bariatric surgery” refers to several different surgical procedures designed to assist weight loss by limiting the amount of food someone eats or the amount they absorb during digestion. It has been used for several years to treat obesity in adults. A new study published in the journal Clinical Obesity reveals that bariatric surgery can result in significant weight loss in severely obese adolescents.

4 Mar 2011

Researchers demonstrate potential neurochemical mechanism of weight loss

An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.

4 Mar 2011

Early diagnosis of juvenile idiopathic arthritis critical to avoid disability, deformity

While lab tests and imaging can sometimes help diagnose juvenile idiopathic arthritis (JIA), a physical examination and thorough patient history are the most valuable tools in identifying this disease. According to a new literature review from the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), the rate of false positives in laboratory evaluations and imaging studies meant to screen for juvenile arthritis makes their value limited.

3 Mar 2011

Reliv fourth-quarter net sales decrease to $18.5 million

Reliv International, Inc. a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth-quarter and full-year of 2010.

2 Mar 2011

Study: Pycnogenol- offers natural solution for patients with metabolic syndrome

The American Heart Association estimates 35 percent of adults in the U.S. suffer from metabolic syndrome, a group of risk factors characterized by obesity and the simultaneous presence of heart disease risk factors with high blood pressure, blood sugar and lipids.

2 Mar 2011

FDA approves roflumilast to treat COPD

The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups or worsening of symptoms from severe chronic obstructive pulmonary disease.

1 Mar 2011

New drug approved for COPD by the FDA

The U.S. FDA has approved a new treatment for people with worsening symptoms of severe chronic obstructive pulmonary disease (COPD). COPD affects smokers and the elderly and leads to severe difficulty in breathing, chronic cough and excessive mucus production. An exacerbation can last up to several weeks and result in a decline in lung function and increased risk of death, and it may be associated with severe anxiety, the FDA says.

1 Mar 2011

FDA approves Forest Labs' Daliresp to treat COPD

Forest Laboratories, Inc. announced today that Daliresp was approved by the U.S. Food and Drug Administration as a treatment to reduce the risk of chronic obstructive pulmonary disease exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

1 Mar 2011

Aetna grants $1 million funding for five obesity research studies

The Aetna Foundation today announced significant funding in support of five research studies designed to deepen understanding of the root causes of the nation's well-documented obesity epidemic and drive viable solutions to the core problems.

28 Feb 2011

BUSM Professor receives funding for research on obesity in African-American women

Boston University School of Medicine (BUSM) is one of five institutions receiving funding from the Aetna Foundation to support research designed to deepen understanding of the root causes of the nation’s well-documented obesity epidemic and drive viable solutions to the core problems. More than $1 million in funding will be granted in support of separate studies at BUSM, New York University School of Medicine, the University of Michigan, the University of Pennsylvania and Yale University’s CARE program.

28 Feb 2011

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.

28 Feb 2011

Study: Fish oil may prevent muscle and weight loss in cancer patients during chemotherapy

A new analysis has found that supplementing the diet with fish oil may prevent muscle and weight loss that commonly occurs in cancer patients who undergo chemotherapy. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that fish oil may help combat cancer-related malnutrition.

28 Feb 2011